Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Halo Collective Profit Margin (Quarterly): -192.0% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -192.0% |
March 31, 2023 | -131.4% |
December 31, 2022 | -1.17K% |
September 30, 2022 | -101.7% |
June 30, 2022 | -163.6% |
March 31, 2022 | -178.4% |
December 31, 2021 | -768.0% |
September 30, 2021 | -115.0% |
June 30, 2021 | -123.2% |
March 31, 2021 | -91.23% |
December 31, 2020 | -452.0% |
September 30, 2020 | -46.37% |
June 30, 2020 | -119.6% |
March 31, 2020 | -193.5% |
December 31, 2019 | -536.5% |
September 30, 2019 | -82.34% |
June 30, 2019 | -43.09% |
March 31, 2019 | -34.17% |
December 31, 2018 | -146.2% |
September 30, 2018 | -149.5% |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 |
Date | Value |
---|---|
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.17K%
Minimum
Dec 2022
-43.09%
Maximum
Jun 2019
-265.3%
Average
-131.4%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
CEN Biotech Inc | -426.2% |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | -59.60% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -448.0% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -152.9% |
Return on Assets | -94.90% |
Return on Invested Capital | -120.0% |
Gross Profit Margin (Quarterly) | 51.34% |
Operating Margin (Quarterly) | -56.30% |
Return on Net Operating Assets | -116.2% |